RapidAI’s AI technology for pulmonary embolism diagnosis gets a nod from FDA
The FDA cleared RapidAI’s technology, which is devised to identify pulmonary embolism, a deadly disease initiated by a clot deep in the body, otherwise known as deep vein thrombosis.